FGAM
GBT

Financial Gravity Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Financial Gravity Asset Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$8K Hold
100
– – 0.01% 1229
2019
Q3 		$5K Hold
100
– – ﹤0.01% 717
2019
Q2 		$5K Hold
100
– – ﹤0.01% 708
2019
Q1 		$5K Buy
+100
New +$4.91K ﹤0.01% 711
2018
Q3 		$4K Hold
100
– – ﹤0.01% 813
2018
Q2 		$5K Buy
+100
New +$4.55K ﹤0.01% 787

Other funds holding GBT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Financial Gravity Asset Management's GBT Position: Q4 2019 in Review

Financial Gravity Asset Management held its Global Blood Therapeutics, Inc. (GBT) position steady in Q4 2019 at 100 shares worth $8K. The position accounts for 0.01% of the portfolio, ranked #1229.

Financial Gravity Asset Management first reported a position in GBT in Q2 2018 and has held it in 6 quarters since. 234 funds tracked by Wall St. Rank hold GBT as of Q4 2019.

  • Financial Gravity Asset Management held 100 shares of Global Blood Therapeutics, Inc. worth $8K as of Q4 2019.
  • Financial Gravity Asset Management left its Global Blood Therapeutics, Inc. share count unchanged in Q4 2019.
  • Global Blood Therapeutics, Inc. made up 0.01% of Financial Gravity Asset Management's portfolio in Q4 2019, its #1229 holding.
  • Financial Gravity Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q2 2018 and has held it in 6 quarters since.
  • 234 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2019.

Based on Financial Gravity Asset Management's 13F filing for Q4 2019, filed 28 Feb 2020.